| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030[J]. PLos Med, 2006, 3(11): e442.
|
| 3 |
Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? [J]. Lancet, 2007, 370(9589): 797-799.
|
| 4 |
Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD[J]. Chest, 2011, 139(1): 165-173.
|
| 5 |
Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation[J]. Thorax, 2008, 63(6): 487- 492.
|
| 6 |
常 春，姚婉贞，方天舒，等. 慢性阻塞性肺疾病住院患者合并症的分布及相关危险因素[J]. 中华医学杂志，2012, 92(14): 943-947.
|
| 7 |
Terzano C, Conti V, Di Stefano F, et al. Comorbidity, hospitalization，and mortality in COPD: results from a longitudinal study[J]. Lung, 2010, 188: 321-329.
|
| 8 |
Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort[J]. Thorax, 2008, 63: 599-605.
|
| 9 |
De la Rosa Carrillo D, Navarro Rolon A, Girón Moreno RM, et al. Cost of Hospitalizations due to Exacerbation in Patients with Non-Cystic Fibrosis Bronchiectasis[J]. Respiration, 2018, 96(5): 406-416.
|
| 10 |
Ko FW, Yan BP, Lam YY, et al. Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress[J]. Respirology, 2016, 21(1): 137-142.
|
| 11 |
杨生岳，冯恩志，闫自强，等. 高原地区慢性阻塞性肺疾病急性加重期合并慢性肺心病抗氧化治疗的研究[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(1): 20-24.
|
| 12 |
Choi BJ, Prasad A, Gulati R, et al. Coronary endothelial dysfunctipon in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque[J]. Eur Heart J, 2013, 34(27): 2047-2054.
|
| 13 |
Trostdorf F, Landgraf C, Kablau M, et al. Increased endothelial cell apoptosis in symptomatic high-grade carotid artery atenosis: preliminary data[J]. Eur J Vase Endovasc Surg, 2007, 33(1): 65-68.
|
| 14 |
De Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients A[J]. Eur Respir J, 2006, 27(5): 902-907.
|
| 15 |
李琛琛，王 蕾. 美托洛尔治疗慢性阻塞性肺疾病合并心血管疾病的疗效分析[J]. 中国现代药物应用，2015, 9(21): 137-138.
|
| 16 |
Feng EZ, Wan RH, Yang SY, et al. Expression levels of induced spiyum IL-8 and IL-10 amd drug intervention effects in patients with acute exacerbated COPD complicated by chronic cor pulmonale at high altitude[J]. Experi and Therap Med, 2013, 6(3): 747-752.
|
| 17 |
Kesten S, Jara M, Wentworth C, et al. Pooled clinical trial analysis of tiotropium safety[J]. Chest, 2006, 130: 1695- 1703.
|
| 18 |
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease, A systematic review and meta-analysis[J]. JAMA, 2008, 300: 1439-1450.
|
| 19 |
Syseth V, Brekke PH, Smith P, et al. Statin use is associated with reduced mortality in COPD[J]. Eur Repir J, 2007, 29(2): 279-283.
|
| 20 |
Schneider C, Jick SS, Bothner U. COPD and the risk of depression[J]. Chest, 2010, 137(2): 341-347.
|
| 21 |
Asnaashati AM, Talaei A, Haghigh B, et al. Evaluation of psychological status in patients with asthma and COPD[J]. J Allergy Asthma lmmuno1, 2012, 11(1): 65-71.
|
| 22 |
Lamin C, Moullec G, Bacon SL, et al. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk[J]. Am J Respir Crit Care Med, 2012, 185(9): 918-923.
|
| 23 |
Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review[J]. lnt J Chron Obstruca Puhnon Dis, 2014, 9: 315-330.
|
| 24 |
司 斌. COPD患者意识障碍原因分析[J]. 中国现代医学杂志，2005, 15(7): 1026-1028.
|
| 25 |
唐鲜娥，潘江其，周发伟，等. Hcy、IL-1β与冠心病患者伴发抑郁的相关性研究[J]. 同济大学学报(医学版), 2017, 38(1): 90-93.
|
| 26 |
Yamanaka K, Chun s J, Boillee S, et al. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis[J]. Nat Neurosci, 2008, 11: 251-253.
|
| 27 |
Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population[J]. Compr Psychiatry, 2001, 42(2): 124-131.
|
| 28 |
李日发. 抗焦虑抑郁辅助治疗在慢性阻塞性肺疾病患者中的临床疗效观察[J]. 临床医学，2017, 40-141.
|
| 29 |
郑丽梅，李 田. 抗抑郁剂治疗对伴有抑郁和焦虑症状的慢性阻塞性肺疾病患者肺功能的影响[J]. 南京医科大学学报,38(2): 247-250.
|
| 30 |
仇国俊. 低渗血症对慢性阻塞性肺疾病并发肺性脑病的影响[J]. 实用医院临床杂志，2007, 4(6): 80-81.
|
| 31 |
Grigorakos L, Sakag ianni K. Outcome of acute heroin overdose requiring intensive care unit admission[J]. Opioid Manag, 2010, 6(3): 227-231.
|
| 32 |
Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts[J]. Diabetes Res Clin Pract, 2010, 87(3): 385-393.
|
| 33 |
Lee CT, Mao IC, Lin CH, et al. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study[J]. Eur J Clin Invest, 2013, 43(11): 1113-1119.
|
| 34 |
Ho TW, Huang CT, Ruan SY, et al. Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality[J]. PLoS One, 2017, 12(4): e0175794.
|
| 35 |
Forgiarini LA Jr, Kretzmann NA, Porawski M, et al. Experimental diabetes mellitus: oxidative stress and changes in lung structure[J]. J Bras Pneumol, 2009, 35(8): 788-791.
|
| 36 |
|
| 37 |
Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD[J]. Chest, 2003, 124(2): 459-467.
|
| 38 |
Hitchings AW, Archer JR, Srivastava SA, et al. Safety of Metformin in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Diabetes Mellitus[J]. COPD, 2015, 12(2): 126-131.
|
| 39 |
Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the towards a revolution in COPD health study[J]. Chest, 2009, 136(6): 1456-1465.
|
| 40 |
Jorgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients[J]. Curr Opin Pulm Med, 2008, 14(2): 122-127.
|
| 41 |
Gosker HR, Kubat B, Schaart G, et al. Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease[J]. Eur Respir J, 2003, 22(2): 280-285.
|
| 42 |
Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease[J]. Thorax, 2007, 62(2): 115-120.
|
| 43 |
Romme EA, Rutten EP, Smeenk FW, et al. Vitamin D statusis asscociated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease[J]. Ann Med, 2013, 45(1): 91-96.
|
| 44 |
王建忠，王春生，王坤正. 阿仑膦酸钠对长期应用糖皮质激素大鼠股骨头骨组织MMP/TIMP系统的影响[J]. 中国骨与关节外科，2011, 4(6): 484-489.
|
| 45 |
Lehouck A, Boonen S, Decramer M, et al. COPD, bone metabolism，and osteoporosis[J]. Chest, 2011, 139(3): 648-657.
|
| 46 |
陈灏珠. 实用内科学(第11版)[M]. 北京，人民卫生出版社，2002, 1554.
|
| 47 |
王永革，安学健，吴显忠. 黄芪注射液在COPD合并胃溃疡中的临床应用[J]. 天津中医，2001, 18(4): 11.
|
| 48 |
梁世廉，李颖莉，李迅维. COPD住院患者合并贫血、低蛋白血症调查[J]. 临床肺科杂志，2016, 21(1): 114-118.
|
| 49 |
邱绪科，张贵兰，龙映瀚，等. 血红蛋白水平与慢性阻塞性肺疾病患者严重程度的相关性分析[J]. 罕少疾病杂志，2018, 25(3): 5-9.
|
| 50 |
John M, Lange A, Hoernig S, et al. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases[J]. Int J Cardiol, 2014, 111(3): 365-370.
|
| 51 |
岑英文，丁 谊. 贫血在慢性阻塞性肺疾病稳定期中发生机制的临床研究[J]. 甘肃医药，2012, 12(9): 881-882.
|
| 52 |
Shorr AF, Doyle J, Stern L, et al. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications[J]. Current Med Res Opin, 2008, 24(4): 1123-1130.
|
| 53 |
Nowinski A, Kaminski D, Korzybski D, et al. The impact of comorbidities on the length treatment in patients with chronic obstructive pulmonary disease[J]. Pneumonlogia Ialergologia Polska, 2011, 79(6): 388-396.
|
| 54 |
刘 素，王若平，华 坚. ATP联合门冬酸钾镁治疗COPD合并急性肾衰26例报告[J]. 山东医药，2000, 40(16): 42-43.
|
| 55 |
陈 聪，张 伟. 从"肺肾相关"探讨慢性阻塞性肺疾病合并骨质疏松症[J]. 山东中医药大学学报，2017, 41(5): 417-418.
|
| 56 |
赵晶晶，李志更，翟志光. 补肺益肾方对稳定期COPD肺肾两虚证疗效评价[J]. 中国中医基础医学杂志，2018, 24(7): 965-966.
|
| 57 |
Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology，economics and evaluation[J]. Can J Urol, 2015, 22 (Suppl 1): 1-6.
|
| 58 |
王 刚，詹 谊，何金参，等. 噻托溴铵吸入剂对合并COPD的良性前列腺增生患者排尿障碍的影响[J]. 实用医学杂志，2017, 33(3): 459-461.
|
| 59 |
Global initial for chronic obstructive lung disease: Gloable strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report). Retrieved on August 1, 2018 at
URL
|
| 60 |
Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on vali-dated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease[J]. Am. J．Respir. Crit. Care Med, 2013, 187: 728-735.
|